Heron Therapeutics Inc. (HRTX)
Sector: | Health Care |
Super Investor Stats: | |
Ownership count: | 0 |
Ownership rank: | -- |
% of all portfolios: | 0% |
| |
Total insider Buys/Sells last 6 months: |
| Transactions | Total |
Buys |
4 |
$287,814 |
Sells |
0 |
$0 |
|
Portfolio Manager |
% of portfolio |
Recent activity |
Shares |
Value |
Open Market Insider Buys
Date Filed |
Reporting Name |
Relationship |
Trans. Date |
Shares |
Price $ |
Total Value $ |
21 Nov 2023 |
FORBES WILLIAM P |
EVP, Chief Development Officer |
17 Nov 2023 |
25,000 |
1.09 |
27,250 |
20 Nov 2023 |
FORBES WILLIAM P |
EVP, Chief Development Officer |
16 Nov 2023 |
50,000 |
0.94 |
46,995 |
17 Nov 2023 |
COLLARD CRAIG A |
Chief Executive Officer |
16 Nov 2023 |
150,000 |
0.92 |
137,970 |
17 Nov 2023 |
DUARTE IRA |
EVP, Chief Financial Officer |
16 Nov 2023 |
85,000 |
0.89 |
75,599 |
25 Jul 2023 |
MORGAN ADAM |
Director |
21 Jul 2023 |
2,486,744 |
1.37 |
3,406,839 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.
P = Preferred Stock